phenylalanine and carbamates

phenylalanine has been researched along with carbamates in 127 studies

Research

Studies (127)

TimeframeStudies, this research(%)All Research%
pre-199012 (9.45)18.7374
1990's13 (10.24)18.2507
2000's48 (37.80)29.6817
2010's24 (18.90)24.3611
2020's30 (23.62)2.80

Authors

AuthorsStudies
Batshaw, M; Brusilow, S; Walser, M1
Hassan, A; Santolucito, JA1
Czernilofsky, AP; Kuechler, E1
Collatz, EE; Czernilofsky, AP; Kuechler, E; Stöffler, G1
Neurath, H; Robinson, NC; Walsh, KA1
Kleinkauf, H; Lipmann, F; Roskoski, R1
Lynn, KR1
Lindsay, DG; Loge, O; Losert, W; Shall, S1
Powers, JC; Robillard, GT; Wilcox, PE1
Coffey, JJ1
Bloom, BR; Ishizaka, T; Quan, PC1
Schulten, HR1
Bakkali-Nadi, A; Malaisse, WJ; Malaisse-Lagae, F1
Gahm, KH; Stalcup, AM1
Brasseur, R; Lins, L; Malaisse, WJ1
Malaisse, WJ2
Bakkali Nadi, A; Malaisse, WJ; Zhang, TM1
Kikuchi, M2
Fuhlendorff, J; Ladrière, L; Leclercq-Meyer, V; Malaisse, WJ1
Grgas, B; Kovarik, Z; Radić, Z; Reiner, E; Simeon-Rudolf, V; Skrinjarić-Spoljar, M1
Asao, T; Fukushima, M; Kakegawa, H; Katunuma, N; Matsui, A; Murata, E; Tada, Y; Tsuge, H; Tsuzuki, H; Turk, D; Turk, V1
Dunning, BE; Hu, S; Wang, S3
Smits, P; Tack, CJ1
Bokvist, K; Buschard, K; Gromada, J; Holst, JJ; Hoy, M; Thomsen, MK1
Bell, PA; Boettcher, BR; Dunning, BE; Fanelli, B; Geisse, S; Hu, S; Schmitz, R; Wang, S1
Füchtenbusch, M; Schatz, H; Standl, E1
Landgraf, R1
Kalbag, JB; McLeod, JF; Nedelman, JR; Walter, YH1
de Souza, CJ; Dunning, BE; Lozito, R; Russo, P1
Dunning, BE; Foley, JE; Pratley, RE1
Abell, AD; Harvey, AJ1
Hu, S; Wang, S1
Sternon, J1
Dornhorst, A1
Nelson, G1
Koivisto, V1
Hu, S1
Ahmann, AJ; Riddle, MC1
Bokvist, K; Gotfredsen, CF; Gromada, J; Hansen, BS; Høy, M; Lindström, P; Olsen, HL; Rorsman, P; Thomsen, MK1
Ashcroft, FM; Carr, RD; Christensen, IT; Hansen, AM; Hansen, JB; Wahl, P1
Davies, MJ1
Göke, B; Parhofer, KG1
Deacon, R; Dunning, BE; Foley, JE; Gutierrez, C; Paladini, S; Valentin, MA1
Birkeland, KI; Bleskestad, IH1
Bokvist, K; Buschard, K; Gromada, J; Holst, JJ; Høy, M; Krogsgaard Thomsen, M; Lindström, P1
Hale, PM; Hollander, P; Khutoryansky, N; Klaff, L; McGill, J; Raskin, P; South, SA1
Yoshida, T; Yoshikawa, T; Yoshioka, K1
Baron, MA1
Haslbeck, M; Jakob, S; Kellerer, M; Linn, T1
Brazinsky, SA; Farrell, J; Hale, PM; Hassman, DR; Khutoryansky, N; Madder, RD; Rosenstock, J1
Gall, MA; Lammert, M; Minshall, ME; Nicklasson, L; Palmer, AJ; Roze, S; Spinas, GA; Valentine, WJ1
Berney, T; Bosco, D; Carr, RD; Donath, MY; Maedler, K; Zuellig, RA1
Blackburn, GL1
Li, JW; Tian, HM; Wang, JN; Yu, HL; Zhang, XX; Zhao, GZ1
Gao, LM; Song, DQ; Yang, P1
Erkent, U; Ertunc, M; Guc, MO; Ilhan, M; Iskit, AB; Onur, R1
Scheen, AJ1
Black, C; Donnelly, P; McIntyre, L; Royle, PL; Shepherd, JP; Thomas, S1
Bieger, S; Kühner, P; Quast, U; Stephan, D; Winkler, M; Wolff, F1
Huang, L; Li, J; Li, Q; Li, Y; Liang, J; Liu, Y; Luo, R; Ni, Z; Tian, H; Wang, N; Wu, T; Yu, H1
Kalliokoski, A; Neuvonen, M; Neuvonen, PJ; Niemi, M1
Kapoor, JR1
Backman, JT; Kalliokoski, A; Neuvonen, PJ; Niemi, M1
Li, C; Wang, L; Wang, S; Xia, J; Zhang, G1
Cornelius, V; Kasliwal, R; Shakir, SA; Vlckova, V; Wilton, L1
Davis, SN1
Aoyagi, K; Nagamatsu, S; Nakamichi, Y; Nishiwaki, C; Ohara-Imaizumi, M1
Longo, R1
Kalliokoski, A; Neuvonen, PJ; Niemi, M1
Blanco, H; Góõmez, MP; Laguna, JJ; Rojas, P; Sánchez, L; Santos, A1
Abdelmoneim, AS; Brocks, DR; Hasenbank, SE; Light, PE; Seubert, JM; Simpson, SH1
Busse, R; Kreis, J1
Jung, JS; Kim, CH; Kim, SJ; Kim, SS; Lim, SM; Park, SH; Sim, YB; Suh, HW1
Chen, M; Hu, C; Jia, W1
DeFronzo, RA; Ferrannini, E1
Black, J; Bream, G; Doekel, R; Emsellem, HA; Feldman, NT; Khayrallah, MA; Lu, Y; Rosenberg, R; Ruoff, C; Swick, TJ1
Bilker, WB; Brensinger, CM; Chiang, C; Han, X; Hennessy, S; Leonard, CE; Li, L1
Hussar, DA2
Black, J; Bogan, RK; Bream, G; Carter, LP; Emsellem, H; Feldman, N; Khayrallah, M; Lankford, A; Lu, Y; Ruoff, C1
Amendola, G; Chouchene, K; Cosconati, S; Ettari, R; Grasso, S; Gut, J; Hellmich, UA; Krauth-Siegel, RL; Previti, S; Rosenthal, PJ; Schirmeister, T; Schmid, I; Ulrich, K; Wagner, A; Wich, PR; Zappalà, M1
Becker, PM; Black, J; Bream, G; Emsellem, HA; Khayrallah, M; Lankford, A; Lu, Y; Ruoff, C; Scrima, L1
Baladi, MG; Carter, LP; Forster, MJ; Gatch, MB; Hyman, DL; Janowsky, A; Mailman, RB1
Carter, LP; Henningfield, JE; Kelsh, D; Lu, Y; Sellers, E; Vince, B; Wang, YG1
Black, J; Carter, LP; Chen, D; Collop, N; Hedner, J; Lee, L; Lorch, DG; Lu, Y; Pépin, JL; Redline, S; Strollo, PJ1
Black, J; Carter, LP; Chen, D; Gotfried, M; Lu, Y; Malhotra, A; Rosenberg, R; Schweitzer, PK; Strohl, KP; Wang, H; Zammit, GK1
Kankam, M; Lu, Y; Zomorodi, K1
Black, J; Carter, LP; Chen, D; Corser, BC; Dauvilliers, Y; Emsellem, H; Lu, Y; Mayer, G; Plazzi, G; Shapiro, C; Thorpy, MJ; Wang, H1
Chen, D; Lasseter, K; Lee, L; Marbury, T; Zomorodi, K1
Gao, J; Yang, J1
Arcara, A; Benfield, M; Brown, J; Crump, LH; Mospan, C; Mospan, G; Ramey, C; Yang, S1
Ahmed, M; Baladi, M; Chandler, P; Foldvary-Schaefer, N; Hedner, J; Lee, L; Malhotra, A; Mayer, G; Pepin, JL; Sarmiento, K; Schwab, R; Shapiro, C; Strollo, PJ1
Black, J; Carter, LP; Chen, D; Dauvilliers, Y; Emsellem, HA; Lammers, GJ; Lee, L; Mayer, G; Menno, D; Plazzi, G; Shapiro, CM; Thorpy, MJ; Villa, KF1
Javaheri, S1
Garland, S; Piszczatoski, C; Powell, J1
Black, J; Carter, LP; Chen, D; Dauvilliers, Y; Emsellem, H; Lammers, GJ; Lee, L; Mayer, G; Plazzi, G; Shapiro, C; Thorpy, MJ1
Earl, DC; Van Tyle, KM1
Carter, LP; Chen, D; Lee, L; Swearingen, D; Zomorodi, K1
Lou, G; Wang, T; Xu, Q; Zhang, L1
Jha, D; K C, B; Ray, BK; Singh, R; Subedi, R; Thakur, RK1
Baladi, M; Chandler, P; Lee, L; Malhotra, A; Mayer, G; Rosenberg, R; Schweitzer, PK; Strohl, KP1
Baladi, M; Bron, M; Rosenberg, R1
Bron, M; Crosby, RD; Mathias, SD; Menno, DM; Morris, S; Weaver, TE1
Chen, G; Gao, H; Li, X; Wang, J; Wang, T; Xu, X; Xu, Z; Yang, S1
Baladi, M; Chandler, P; Gotfried, M; Malhotra, A; Mayer, G; Rosenberg, R; Schweitzer, PK; Strohl, KP; Zammit, GK1
Alamiri, B; El-Sheshaie, A; Elsori, DH; Naguy, A1
Cavalli, F; Franceschini, C; Pizza, F; Plazzi, G1
Béni, S; Fejős, I; Köteles, I; Malanga, M; Szabó, ZI; Tóth, G; Várnai, B1
Amara, AW; Comella, C; Emsellem, H; Gottwald, MD; Hauser, RA; Jochelson, P; Liu, K; Schweitzer, PK; Steinerman, JR; Sterkel, AL; Videnovic, A; Zomorodi, K1
Bujanover, S; Dauvilliers, Y; Gotfried, M; Malhotra, A; Rosenberg, R; Scheckner, B; Schweitzer, PK; Thorpy, MJ; Zammit, G1
Bron, M; Bujanover, S; Kratochvil, D; Lucas, E; Menno, D; Patel, D; Ronnebaum, S; Stepnowsky, C1
Belliard, S; Berrebi-Bertrand, I; Finance, O; Giret, M; Krief, S; Lecomte, JM; Ligneau, X; Nagmar, I; Perrin, D; Robert, P; Schwartz, JC; Uguen, M1
Ahmed, M; Baladi, M; Bron, M; Chandler, P; Foldvary-Schaefer, N; Hedner, J; Lee, L; Malhotra, A; Mayer, G; Pepin, JL; Sarmiento, K; Schwab, R; Shapiro, C; Strollo, PJ; Weaver, TE1
Blom, TJ; Guerdjikova, AI; McElroy, SL; Mori, N; Romo-Nava, F1
Asin, J; Carter, LP; Chen, D; de Vries, N; Donjacour, CEHM; Janssen, H; Lammers, GJ; Overeem, S; Ramaekers, JG; Vermeeren, A; Vinckenbosch, F; Vonk, PE; Wang, G; Zhou, K1
Armstrong, DW; Berkecz, R; Forró, E; Ilisz, I; Péter, A; Shahmohammadi, S; Tanács, D1
Baldys, B; Chen, A; Foley, C; Hyman, D; Ito, D; Parks, GS; Singh, H; Thorpy, MJ1
Bahrami, K; Järvinen, J; Rautio, J; Srisongkram, T; Timonen, J; Weerapreeyakul, N1
Babson, K; Benca, RM; Bujanover, S; Krystal, AD; Lee, L; Malhotra, A; Rosenberg, R; Schweitzer, PK; Strohl, KP1
Carter, LP; Chen, D; Lammers, GJ; Overeem, S; Ramaekers, JG; Vermeeren, A; Vinckenbosch, F; Wang, G; Zhou, K1

Reviews

34 review(s) available for phenylalanine and carbamates

ArticleYear
Modulation of insulin secretion in non-insulin-dependent diabetes mellitus by two novel oral hypoglycaemic agents, NN623 and A4166.
    Diabetic medicine : a journal of the British Diabetic Association, 1996, Volume: 13, Issue:9 Suppl 6

    Topics: Administration, Oral; Biological Availability; Blood Glucose; Carbamates; Cyclohexanes; Diabetes Mellitus, Type 2; Glyburide; Humans; Hypoglycemic Agents; Insulin; Insulin Secretion; Intestinal Absorption; Molecular Structure; Nateglinide; Phenylalanine; Piperidines; Reference Values; Stereoisomerism

1996
New drugs for diabetes.
    The Netherlands journal of medicine, 1999, Volume: 55, Issue:5

    Topics: Carbamates; Chromans; Cyclohexanes; Diabetes Mellitus, Type 2; Humans; Hypoglycemic Agents; Insulin Resistance; Metformin; Nateglinide; Phenylalanine; Piperidines; Thiazoles; Thiazolidinediones; Troglitazone

1999
Clinical efficacy of new thiazolidinediones and glinides in the treatment of type 2 diabetes mellitus.
    Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association, 2000, Volume: 108, Issue:3

    Topics: Carbamates; Cyclohexanes; Diabetes Mellitus, Type 2; Drug Therapy, Combination; Glycated Hemoglobin; Humans; Hypoglycemic Agents; Nateglinide; Phenylalanine; Pioglitazone; Piperidines; Rosiglitazone; Thiazoles; Thiazolidinediones

2000
Meglitinide analogues in the treatment of type 2 diabetes mellitus.
    Drugs & aging, 2000, Volume: 17, Issue:5

    Topics: Benzamides; Carbamates; Cyclohexanes; Diabetes Mellitus, Type 2; Glyburide; Humans; Hypoglycemic Agents; Molecular Structure; Nateglinide; Phenylalanine; Piperidines

2000
Rapid acting insulinotropic agents: restoration of early insulin secretion as a physiologic approach to improve glucose control.
    Current pharmaceutical design, 2001, Volume: 7, Issue:14

    Topics: Animals; Carbamates; Cyclohexanes; Diabetes Mellitus, Type 2; Glucose; Guanidines; Humans; Hypoglycemic Agents; Indoles; Insulin; Insulin Secretion; Isoindoles; Nateglinide; Phenylalanine; Piperidines

2001
[New drugs].
    Revue medicale de Bruxelles, 2001, Volume: 22, Issue:4

    Topics: Amdinocillin; Carbamates; Clopidogrel; Cyclohexanes; Drug Interactions; Humans; Hypoglycemic Agents; Nateglinide; Patient Selection; Penicillins; Phenylalanine; Piperidines; Platelet Aggregation Inhibitors; Pneumococcal Vaccines; Raloxifene Hydrochloride; Safety; Selective Estrogen Receptor Modulators; Ticlopidine

2001
Insulinotropic meglitinide analogues.
    Lancet (London, England), 2001, Nov-17, Volume: 358, Issue:9294

    Topics: Adult; Animals; Benzamides; Carbamates; Cyclohexanes; Diabetes Mellitus, Type 2; Humans; Hypoglycemic Agents; Insulin; Insulin Secretion; Nateglinide; Phenylalanine; Piperidines; Rats

2001
[Insulin analogs and new oral antidiabetic drugs].
    Duodecim; laaketieteellinen aikakauskirja, 1999, Volume: 115, Issue:20

    Topics: Administration, Oral; Carbamates; Cyclohexanes; Diabetes Mellitus; Dose-Response Relationship, Drug; Glucose; Humans; Hypoglycemic Agents; Insulin; Insulin Secretion; Nateglinide; Phenylalanine; Piperidines; Receptors, Cytoplasmic and Nuclear; Thiazoles; Thiazolidinediones; Transcription Factors

1999
Current oral agents for type 2 diabetes. Many options, but which to choose when?
    Postgraduate medicine, 2002, Volume: 111, Issue:5

    Topics: Carbamates; Cyclohexanes; Diabetes Mellitus, Type 2; Drug Monitoring; Drug Therapy, Combination; Glycoside Hydrolases; Humans; Hypoglycemic Agents; Metformin; Nateglinide; Phenylalanine; Piperidines; Receptors, Cytoplasmic and Nuclear; Sulfonylurea Compounds; Transcription Factors

2002
Insulin secretagogues.
    Current medical research and opinion, 2002, Volume: 18 Suppl 1

    Topics: Carbamates; Cyclohexanes; Diabetes Mellitus, Type 2; Glycated Hemoglobin; Humans; Hyperglycemia; Hyperinsulinism; Hypoglycemic Agents; Insulin; Insulin Secretion; Islets of Langerhans; Nateglinide; Phenylalanine; Piperidines; Postprandial Period; Sulfonylurea Compounds; United Kingdom

2002
[Structures and mechanisms for non SU insulin secretagogues].
    Nihon rinsho. Japanese journal of clinical medicine, 2002, Volume: 60 Suppl 9

    Topics: Adenosine Triphosphate; Animals; ATP-Binding Cassette Transporters; Calcium Channels; Carbamates; Cyclohexanes; Exocytosis; Humans; Hypoglycemic Agents; Indoles; Insulin; Insulin Secretion; Islets of Langerhans; Isoindoles; Nateglinide; Organ Specificity; Phenylalanine; Piperidines; Potassium Channels; Potassium Channels, Inwardly Rectifying; Receptors, Drug; Sulfonylurea Receptors

2002
[symbol: see text] Nateglinide and [symbol: see text] repaglinide for type 2 diabetes?
    Drug and therapeutics bulletin, 2003, Volume: 41, Issue:7

    Topics: Carbamates; Cyclohexanes; Diabetes Mellitus, Type 2; Double-Blind Method; Humans; Hypoglycemic Agents; Nateglinide; Phenylalanine; Piperidines; Randomized Controlled Trials as Topic; Treatment Outcome

2003
[Continuation 50. Type 2 diabetes: possibilities and limitations of pharmacological therapy].
    MMW Fortschritte der Medizin, 2003, Dec-18, Volume: 145, Issue:51-52

    Topics: 1-Deoxynojirimycin; Acarbose; Aged; Blood Glucose; Carbamates; Contraindications; Cyclohexanes; Diabetes Mellitus, Type 2; Drug Therapy, Combination; Enzyme Inhibitors; Fasting; Follow-Up Studies; Germany; Glucosamine; Glyburide; Glycated Hemoglobin; Glycoside Hydrolase Inhibitors; Humans; Hypoglycemia; Hypoglycemic Agents; Imino Pyranoses; Insulin; Metformin; Middle Aged; Nateglinide; Obesity; Patient Compliance; Phenylalanine; Pioglitazone; Piperidines; Practice Guidelines as Topic; Risk Factors; Rosiglitazone; Sulfonylurea Compounds; Thiazolidinediones; Time Factors

2003
Pharmacology of the meglitinide analogs: new treatment options for type 2 diabetes mellitus.
    Treatments in endocrinology, 2003, Volume: 2, Issue:6

    Topics: Animals; Benzamides; Carbamates; Cyclohexanes; Diabetes Mellitus, Type 2; Humans; Hypoglycemic Agents; Nateglinide; Phenylalanine; Piperidines

2003
Drug-drug and food-drug pharmacokinetic interactions with new insulinotropic agents repaglinide and nateglinide.
    Clinical pharmacokinetics, 2007, Volume: 46, Issue:2

    Topics: Anti-Bacterial Agents; Area Under Curve; Biological Availability; Biotransformation; Carbamates; Cyclohexanes; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Drug Administration Schedule; Drug Interactions; Enzyme Induction; Enzyme Inhibitors; Fasting; Food-Drug Interactions; Humans; Hypoglycemic Agents; Intestinal Absorption; Nateglinide; Phenylalanine; Piperidines; Postprandial Period

2007
Meglitinide analogues for type 2 diabetes mellitus.
    The Cochrane database of systematic reviews, 2007, Apr-18, Issue:2

    Topics: Benzamides; Carbamates; Cyclohexanes; Diabetes Mellitus, Type 2; Humans; Hypoglycemic Agents; Metformin; Nateglinide; Phenylalanine; Piperidines; Randomized Controlled Trials as Topic

2007
Drugs for type 2 diabetes.
    Treatment guidelines from the Medical Letter, 2008, Volume: 6, Issue:71

    Topics: alpha-Galactosidase; Biguanides; Carbamates; Cyclohexanes; Diabetes Mellitus, Type 2; Drug Combinations; Drug Therapy, Combination; Humans; Hypoglycemic Agents; Insulin; Nateglinide; Phenylalanine; Piperidines; Pyrazines; Sitagliptin Phosphate; Sulfonylurea Compounds; Thiazolidinediones; Triazoles

2008
Nateglinide versus repaglinide for type 2 diabetes mellitus in China.
    Acta diabetologica, 2009, Volume: 46, Issue:4

    Topics: Carbamates; China; Cyclohexanes; Diabetes Mellitus, Type 2; Female; Glycated Hemoglobin; Humans; Hypoglycemic Agents; Male; Middle Aged; Nateglinide; Phenylalanine; Piperidines

2009
Advances in oral therapy for type 2 diabetes.
    Postgraduate medicine, 2000, May-15, Volume: 107, Issue:6 Suppl Ke

    Topics: Acarbose; Administration, Oral; Blood Glucose; Carbamates; Cyclohexanes; Diabetes Mellitus, Type 2; Drug Combinations; Drug Therapy, Combination; Glycated Hemoglobin; Humans; Hypoglycemia; Hypoglycemic Agents; Insulin; Insulin Secretion; Insulin-Secreting Cells; Metformin; Nateglinide; Phenylalanine; Piperidines; Randomized Controlled Trials as Topic; Thiazolidinediones; United States; Weight Gain

2000
SLCO1B1 polymorphism and oral antidiabetic drugs.
    Basic & clinical pharmacology & toxicology, 2010, Volume: 107, Issue:4

    Topics: Administration, Oral; Alleles; Carbamates; Cyclohexanes; Genotype; Haplotypes; Humans; Hypoglycemic Agents; Liver-Specific Organic Anion Transporter 1; Nateglinide; Organic Anion Transporters; Phenylalanine; Pioglitazone; Piperidines; Polymorphism, Genetic; Rosiglitazone; Thiazolidinediones

2010
Variations in tissue selectivity amongst insulin secretagogues: a systematic review.
    Diabetes, obesity & metabolism, 2012, Volume: 14, Issue:2

    Topics: Animals; ATP-Binding Cassette Transporters; Carbamates; Cardiovascular Diseases; Cricetinae; Cyclohexanes; Diabetes Mellitus, Type 2; Gliclazide; Glipizide; Glyburide; Humans; Hypoglycemic Agents; Ischemic Preconditioning, Myocardial; Isoindoles; Mice; Muscle, Smooth, Vascular; Myocytes, Cardiac; Nateglinide; Phenylalanine; Piperidines; Potassium Channels, Inwardly Rectifying; Rats; Receptors, Drug; Risk Factors; Sulfonylurea Compounds; Sulfonylurea Receptors; Tolbutamide

2012
Pharmacogenomics of glinides.
    Pharmacogenomics, 2015, Volume: 16, Issue:1

    Topics: Carbamates; Cyclohexanes; Diabetes Mellitus, Type 2; Humans; Hypoglycemic Agents; Inactivation, Metabolic; Insulin; Insulin Secretion; Insulin-Secreting Cells; Isoindoles; KATP Channels; Nateglinide; Pharmacogenetics; Phenylalanine; Piperidines

2015
Impact of glucose-lowering drugs on cardiovascular disease in type 2 diabetes.
    European heart journal, 2015, Sep-07, Volume: 36, Issue:34

    Topics: Carbamates; Clinical Trials as Topic; Coronary Artery Disease; Cyclohexanes; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Dipeptidyl-Peptidase IV Inhibitors; Glucagon-Like Peptide-1 Receptor; Glycoside Hydrolase Inhibitors; Humans; Hypoglycemic Agents; Insulin; Metformin; Nateglinide; Phenylalanine; Piperidines; Sodium-Glucose Transport Proteins; Sulfonylurea Compounds; Thiazolidinediones; Treatment Outcome

2015
NewDrugs 2017, part 2.
    Nursing, 2017, Volume: 47, Issue:7

    Topics: Amides; Antibodies, Monoclonal, Humanized; Benzofurans; Carbamates; Cyclopropanes; Drug Approval; Drug Therapy; gamma-Cyclodextrins; Heterocyclic Compounds, 4 or More Rings; Humans; Imidazoles; Peptides; Phenylalanine; Quinoxalines; Sofosbuvir; Sugammadex; Sulfonamides; Sulfones; Thioglycolates; Triazoles; United States; United States Food and Drug Administration

2017
Solriamfetol for the treatment of excessive daytime sleepiness associated with narcolepsy.
    Expert review of clinical pharmacology, 2019, Volume: 12, Issue:8

    Topics: Adrenergic Uptake Inhibitors; Animals; Carbamates; Disorders of Excessive Somnolence; Dopamine Uptake Inhibitors; Humans; Narcolepsy; Phenylalanine; Treatment Outcome

2019
Solriamfetol (Sunosi) for excessive daytime sleepiness.
    The Medical letter on drugs and therapeutics, 2019, Aug-26, Volume: 61, Issue:1579

    Topics: Adrenergic Uptake Inhibitors; Carbamates; Dopamine Uptake Inhibitors; Humans; Phenylalanine; Randomized Controlled Trials as Topic; Sleepiness

2019
Update on Persistent Excessive Daytime Sleepiness in OSA.
    Chest, 2020, Volume: 158, Issue:2

    Topics: Carbamates; Disorders of Excessive Somnolence; Humans; Modafinil; Phenylalanine; Piperidines; Sleep Apnea, Obstructive; Wakefulness-Promoting Agents

2020
Solriamfetol for Excessive Sleepiness in Narcolepsy and Obstructive Sleep Apnea.
    The Annals of pharmacotherapy, 2020, Volume: 54, Issue:10

    Topics: Carbamates; Clinical Trials as Topic; Disorders of Excessive Somnolence; Humans; Narcolepsy; Phenylalanine; Sleep Apnea, Obstructive; Sleepiness; Treatment Outcome; United States; United States Food and Drug Administration; Wakefulness-Promoting Agents

2020
New pharmacologic agents for insomnia and hypersomnia.
    Current opinion in pulmonary medicine, 2020, Volume: 26, Issue:6

    Topics: Azepines; Carbamates; Dementia; Disorders of Excessive Somnolence; GABA-A Receptor Agonists; Humans; Orexin Receptor Antagonists; Phenylalanine; Piperidines; Pyridines; Pyrimidines; Sleep Aids, Pharmaceutical; Sleep Apnea, Obstructive; Sleep Initiation and Maintenance Disorders; Trazodone; Triazoles; Zolpidem

2020
[Advances in treatment of narcolepsy].
    Zhejiang da xue xue bao. Yi xue ban = Journal of Zhejiang University. Medical sciences, 2020, Aug-25, Volume: 49, Issue:4

    Topics: Carbamates; Cataplexy; Drug Development; Humans; Narcolepsy; Phenylalanine; Piperidines

2020
Efficacy and safety of solriamfetol for excessive daytime sleepiness in narcolepsy and obstructive sleep apnea: a systematic review and meta-analysis of clinical trials.
    Sleep medicine, 2020, Volume: 75

    Topics: Carbamates; Disorders of Excessive Somnolence; Humans; Narcolepsy; Phenylalanine; Sleep Apnea, Obstructive

2020
Efficacy and safety of solriamfetol for excessive sleepiness in narcolepsy and obstructive sleep apnea: findings from randomized controlled trials.
    Sleep medicine, 2021, Volume: 79

    Topics: Adult; Carbamates; Disorders of Excessive Somnolence; Humans; Narcolepsy; Phenylalanine; Randomized Controlled Trials as Topic; Sleep Apnea, Obstructive; Sleepiness

2021
A practical guide to the pharmacological and behavioral therapy of Narcolepsy.
    Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics, 2021, Volume: 18, Issue:1

    Topics: Behavior Therapy; Carbamates; Counseling; Humans; Modafinil; Narcolepsy; Phenylalanine; Piperidines; Wakefulness-Promoting Agents

2021
Indirect treatment comparison of solriamfetol, modafinil, and armodafinil for excessive daytime sleepiness in obstructive sleep apnea.
    Journal of clinical sleep medicine : JCSM : official publication of the American Academy of Sleep Medicine, 2021, 12-01, Volume: 17, Issue:12

    Topics: Benzhydryl Compounds; Carbamates; Disorders of Excessive Somnolence; Double-Blind Method; Humans; Modafinil; Phenylalanine; Sleep Apnea, Obstructive; Treatment Outcome

2021

Trials

31 trial(s) available for phenylalanine and carbamates

ArticleYear
Modulation of insulin secretion in non-insulin-dependent diabetes mellitus by two novel oral hypoglycaemic agents, NN623 and A4166.
    Diabetic medicine : a journal of the British Diabetic Association, 1996, Volume: 13, Issue:9 Suppl 6

    Topics: Administration, Oral; Biological Availability; Blood Glucose; Carbamates; Cyclohexanes; Diabetes Mellitus, Type 2; Glyburide; Humans; Hypoglycemic Agents; Insulin; Insulin Secretion; Intestinal Absorption; Molecular Structure; Nateglinide; Phenylalanine; Piperidines; Reference Values; Stereoisomerism

1996
Mealtime glucose regulation with nateglinide in healthy volunteers: comparison with repaglinide and placebo.
    Diabetes care, 2001, Volume: 24, Issue:1

    Topics: Adolescent; Adult; Blood Glucose; Body Mass Index; Body Weight; Carbamates; Cross-Over Studies; Cyclohexanes; Female; Food; Humans; Hypoglycemic Agents; Insulin; Insulin Secretion; Kinetics; Male; Middle Aged; Nateglinide; Phenylalanine; Piperidines; Placebos; Time Factors

2001
Efficacy and safety of combination therapy: repaglinide plus metformin versus nateglinide plus metformin.
    Diabetes care, 2003, Volume: 26, Issue:7

    Topics: Area Under Curve; Blood Glucose; Carbamates; Cyclohexanes; Diabetes Mellitus, Type 2; Drug Therapy, Combination; Female; Glycated Hemoglobin; Humans; Hypoglycemic Agents; Insulin; Male; Metformin; Middle Aged; Nateglinide; Phenylalanine; Piperidines; Postprandial Period; Safety

2003
Repaglinide versus nateglinide monotherapy: a randomized, multicenter study.
    Diabetes care, 2004, Volume: 27, Issue:6

    Topics: Biomarkers; Body Mass Index; Carbamates; Cyclohexanes; Diabetes Mellitus, Type 2; Diet, Diabetic; Exercise; Female; Glycated Hemoglobin; Humans; Hypoglycemic Agents; Male; Middle Aged; Nateglinide; Phenylalanine; Piperidines; Time Factors

2004
[Comparison of efficacy between nateglinide and repaglinide in treating type 2 diabetes: a randomized controlled double-blind clinical trial].
    Sichuan da xue xue bao. Yi xue ban = Journal of Sichuan University. Medical science edition, 2005, Volume: 36, Issue:2

    Topics: Adult; Blood Glucose; Carbamates; Cyclohexanes; Diabetes Mellitus, Type 2; Double-Blind Method; Female; Humans; Hypoglycemic Agents; Insulin; Insulin Secretion; Male; Middle Aged; Nateglinide; Phenylalanine; Piperidines

2005
Improvement of insulin sensitivity and beta-cell function by nateglinide and repaglinide in type 2 diabetic patients - a randomized controlled double-blind and double-dummy multicentre clinical trial.
    Diabetes, obesity & metabolism, 2007, Volume: 9, Issue:4

    Topics: Adult; Age of Onset; Aged; Area Under Curve; Asian People; Blood Glucose; Carbamates; China; Cyclohexanes; Diabetes Mellitus, Type 2; Double-Blind Method; Humans; Insulin; Insulin Secretion; Insulin-Secreting Cells; Middle Aged; Nateglinide; Phenylalanine; Piperidines

2007
Different effects of SLCO1B1 polymorphism on the pharmacokinetics and pharmacodynamics of repaglinide and nateglinide.
    Journal of clinical pharmacology, 2008, Volume: 48, Issue:3

    Topics: Analysis of Variance; Area Under Curve; Aryl Hydrocarbon Hydroxylases; Blood Glucose; Carbamates; Chromatography, Liquid; Cyclohexanes; Cytochrome P-450 CYP2C8; Cytochrome P-450 CYP2C9; Dose-Response Relationship, Drug; Genotype; Half-Life; Humans; Hypoglycemic Agents; Liver-Specific Organic Anion Transporter 1; Metabolic Clearance Rate; Molecular Structure; Nateglinide; Organic Anion Transporters; Pharmacogenetics; Phenylalanine; Piperidines; Polymorphism, Single Nucleotide; Tablets; Tandem Mass Spectrometry

2008
Effects of the SLCO1B1*1B haplotype on the pharmacokinetics and pharmacodynamics of repaglinide and nateglinide.
    Pharmacogenetics and genomics, 2008, Volume: 18, Issue:11

    Topics: Administration, Oral; Adult; Area Under Curve; Blood Glucose; Carbamates; Cyclohexanes; Female; Haplotypes; Humans; Hypoglycemic Agents; Liver-Specific Organic Anion Transporter 1; Male; Nateglinide; Organic Anion Transporters; Phenylalanine; Piperidines; Time Factors

2008
Nateglinide versus repaglinide for type 2 diabetes mellitus in China.
    Acta diabetologica, 2009, Volume: 46, Issue:4

    Topics: Carbamates; China; Cyclohexanes; Diabetes Mellitus, Type 2; Female; Glycated Hemoglobin; Humans; Hypoglycemic Agents; Male; Middle Aged; Nateglinide; Phenylalanine; Piperidines

2009
Effect of Oral JZP-110 (ADX-N05) on Wakefulness and Sleepiness in Adults with Narcolepsy: A Phase 2b Study.
    Sleep, 2016, Jul-01, Volume: 39, Issue:7

    Topics: Adult; Aged; Carbamates; Double-Blind Method; Drug Administration Schedule; Female; Follow-Up Studies; Humans; Male; Middle Aged; Narcolepsy; Phenylalanine; Sleep Stages; Treatment Outcome; Wakefulness; Wakefulness-Promoting Agents

2016
Evaluation of the effect of JZP-110 in patients with narcolepsy assessed using the Maintenance of Wakefulness Test censored to 20 minutes.
    Sleep medicine, 2017, Volume: 35

    Topics: Adult; Carbamates; Cross-Over Studies; Female; Humans; Male; Narcolepsy; Phenylalanine; Sleep; Time Factors; Treatment Outcome; Wakefulness; Wakefulness-Promoting Agents

2017
Identifying clinically important difference on the Epworth Sleepiness Scale: results from a narcolepsy clinical trial of JZP-110.
    Sleep medicine, 2017, Volume: 38

    Topics: Adult; Area Under Curve; Carbamates; Double-Blind Method; Female; Humans; Male; Narcolepsy; Phenylalanine; ROC Curve; Severity of Illness Index; Treatment Outcome; Wakefulness-Promoting Agents

2017
A randomized, double-blind, placebo-controlled, crossover study to evaluate the human abuse liability of solriamfetol, a selective dopamine and norepinephrine reuptake inhibitor.
    Journal of psychopharmacology (Oxford, England), 2018, Volume: 32, Issue:12

    Topics: Adrenergic Uptake Inhibitors; Adult; Carbamates; Cross-Over Studies; Dopamine Uptake Inhibitors; Dose-Response Relationship, Drug; Double-Blind Method; Female; Humans; Male; Phentermine; Phenylalanine; Substance-Related Disorders; Young Adult

2018
Solriamfetol for the Treatment of Excessive Sleepiness in OSA: A Placebo-Controlled Randomized Withdrawal Study.
    Chest, 2019, Volume: 155, Issue:2

    Topics: Adult; Aged; Carbamates; Double-Blind Method; Drug Administration Schedule; Female; Humans; Male; Middle Aged; Phenylalanine; Sleep Apnea, Obstructive; Sleepiness; Treatment Outcome; Wakefulness

2019
Solriamfetol for Excessive Sleepiness in Obstructive Sleep Apnea (TONES 3). A Randomized Controlled Trial.
    American journal of respiratory and critical care medicine, 2019, 06-01, Volume: 199, Issue:11

    Topics: Adult; Aged; Carbamates; Disorders of Excessive Somnolence; Dopamine Uptake Inhibitors; Double-Blind Method; Female; Humans; Male; Middle Aged; Norepinephrine Plasma Membrane Transport Proteins; Phenylalanine; Sleep Apnea, Obstructive

2019
A Phase I, Randomized, Crossover, Open-label Study of the Pharmacokinetics of Solriamfetol (JZP-110) in Healthy Adult Subjects With and Without Food.
    Clinical therapeutics, 2019, Volume: 41, Issue:2

    Topics: Adult; Area Under Curve; Biological Availability; Carbamates; Cross-Over Studies; Fasting; Female; Food-Drug Interactions; Healthy Volunteers; Humans; Male; Middle Aged; Phenylalanine; Therapeutic Equivalency

2019
A randomized study of solriamfetol for excessive sleepiness in narcolepsy.
    Annals of neurology, 2019, Volume: 85, Issue:3

    Topics: Adult; Carbamates; Double-Blind Method; Female; Humans; Male; Middle Aged; Narcolepsy; Phenylalanine; Sleep Latency; Sleepiness; Treatment Outcome; Wakefulness-Promoting Agents; Young Adult

2019
Single-Dose Pharmacokinetics and Safety of Solriamfetol in Participants With Normal or Impaired Renal Function and With End-Stage Renal Disease Requiring Hemodialysis.
    Journal of clinical pharmacology, 2019, Volume: 59, Issue:8

    Topics: Adult; Aged; Carbamates; Female; Humans; Kidney; Kidney Failure, Chronic; Male; Middle Aged; Models, Biological; Neurotransmitter Uptake Inhibitors; Phenylalanine; Renal Dialysis; Renal Insufficiency

2019
Long-term study of the safety and maintenance of efficacy of solriamfetol (JZP-110) in the treatment of excessive sleepiness in participants with narcolepsy or obstructive sleep apnea.
    Sleep, 2020, 02-13, Volume: 43, Issue:2

    Topics: Carbamates; Disorders of Excessive Somnolence; Double-Blind Method; Humans; Narcolepsy; Phenylalanine; Sleep Apnea, Obstructive; Sleepiness; Treatment Outcome

2020
Measures of functional outcomes, work productivity, and quality of life from a randomized, phase 3 study of solriamfetol in participants with narcolepsy.
    Sleep medicine, 2020, Volume: 67

    Topics: Adult; Carbamates; Disorders of Excessive Somnolence; Double-Blind Method; Efficiency; Female; Humans; Male; Narcolepsy; Phenylalanine; Physical Functional Performance; Quality of Life; Surveys and Questionnaires; Wakefulness

2020
Solriamfetol for the Treatment of Excessive Daytime Sleepiness in Participants with Narcolepsy with and without Cataplexy: Subgroup Analysis of Efficacy and Safety Data by Cataplexy Status in a Randomized Controlled Trial.
    CNS drugs, 2020, Volume: 34, Issue:7

    Topics: Adult; Carbamates; Cataplexy; Disorders of Excessive Somnolence; Double-Blind Method; Female; Humans; Male; Narcolepsy; Phenylalanine; Treatment Outcome; Wakefulness

2020
A Randomized, Double-Blind, Placebo- and Positive-Controlled, 4-Period Crossover Study of the Effects of Solriamfetol on QTcF Intervals in Healthy Participants.
    Clinical pharmacology in drug development, 2021, Volume: 10, Issue:4

    Topics: Adrenergic Uptake Inhibitors; Adult; Carbamates; Cross-Over Studies; Dopamine Uptake Inhibitors; Dose-Response Relationship, Drug; Double-Blind Method; Electrocardiography; Female; Humans; Long QT Syndrome; Male; Middle Aged; Moxifloxacin; Phenylalanine; Young Adult

2021
Effects of solriamfetol in a long-term trial of participants with obstructive sleep apnea who are adherent or nonadherent to airway therapy.
    Journal of clinical sleep medicine : JCSM : official publication of the American Academy of Sleep Medicine, 2021, 04-01, Volume: 17, Issue:4

    Topics: Carbamates; Continuous Positive Airway Pressure; Disorders of Excessive Somnolence; Humans; Phenylalanine; Sleep Apnea, Obstructive; Treatment Outcome

2021
Determination of thresholds for minimally important difference and clinically important response on the functional outcomes of sleep questionnaire short version in adults with narcolepsy or obstructive sleep apnea.
    Sleep & breathing = Schlaf & Atmung, 2021, Volume: 25, Issue:3

    Topics: Adolescent; Adult; Aged; Carbamates; Female; Humans; Male; Middle Aged; Narcolepsy; Phenylalanine; Sleep Apnea, Obstructive; Surveys and Questionnaires; Treatment Outcome; Young Adult

2021
Randomized Controlled Trial of Solriamfetol for Excessive Daytime Sleepiness in OSA: An Analysis of Subgroups Adherent or Nonadherent to OSA Treatment.
    Chest, 2021, Volume: 160, Issue:1

    Topics: Adolescent; Adult; Aged; Carbamates; Disorders of Excessive Somnolence; Double-Blind Method; Female; Health Status; Humans; Male; Middle Aged; Patient Compliance; Phenylalanine; Sleep; Sleep Apnea, Obstructive; Wakefulness; Young Adult

2021
Solriamfetol for Excessive Daytime Sleepiness in Parkinson's Disease: Phase 2 Proof-of-Concept Trial.
    Movement disorders : official journal of the Movement Disorder Society, 2021, Volume: 36, Issue:10

    Topics: Adult; Carbamates; Disorders of Excessive Somnolence; Double-Blind Method; Humans; Parkinson Disease; Phenylalanine

2021
Incidence and duration of common early-onset adverse events in randomized controlled trials of solriamfetol for treatment of excessive daytime sleepiness in obstructive sleep apnea and narcolepsy.
    Journal of clinical sleep medicine : JCSM : official publication of the American Academy of Sleep Medicine, 2022, 01-01, Volume: 18, Issue:1

    Topics: Carbamates; Disorders of Excessive Somnolence; Humans; Incidence; Narcolepsy; Phenylalanine; Randomized Controlled Trials as Topic; Sleep Apnea, Obstructive; Treatment Outcome

2022
Study protocol and rationale for a randomized, placebo-controlled trial of solriamfetol to treat binge eating disorder.
    Contemporary clinical trials, 2021, Volume: 110

    Topics: Binge-Eating Disorder; Carbamates; Double-Blind Method; Humans; Phenylalanine; Randomized Controlled Trials as Topic; Treatment Outcome

2021
Effects of solriamfetol on on-the-road driving performance in participants with excessive daytime sleepiness associated with obstructive sleep apnoea.
    Human psychopharmacology, 2022, Volume: 37, Issue:6

    Topics: Carbamates; Disorders of Excessive Somnolence; Humans; Phenylalanine; Sleep Apnea, Obstructive

2022
Solriamfetol treatment of excessive daytime sleepiness in participants with narcolepsy or obstructive sleep apnea with a history of depression.
    Journal of psychiatric research, 2022, Volume: 155

    Topics: Carbamates; Depression; Disorders of Excessive Somnolence; Double-Blind Method; Humans; Narcolepsy; Phenylalanine; Sleep Apnea, Obstructive; Treatment Outcome

2022
Effects of solriamfetol on on-the-road driving in participants with narcolepsy: A randomised crossover trial.
    Human psychopharmacology, 2023, Volume: 38, Issue:1

    Topics: Adult; Automobile Driving; Carbamates; Cross-Over Studies; Double-Blind Method; Female; Humans; Male; Narcolepsy; Phenylalanine

2023

Other Studies

64 other study(ies) available for phenylalanine and carbamates

ArticleYear
Treatment of carbamyl phosphate synthetase deficiency with keto analogues of essential amino acids.
    The New England journal of medicine, 1975, May-22, Volume: 292, Issue:21

    Topics: Adolescent; Amino Acids; Amino Acids, Essential; Ammonia; Carbamates; Child; Child, Preschool; Circadian Rhythm; Female; Humans; Infant; Infant, Newborn; Injections, Intravenous; Isoleucine; Keto Acids; Leucine; Liver; Methionine; Nitrogen; Phenylalanine; Phosphotransferases; Urea; Valine

1975
Pharmacological effects of carbaryl. II. Modification of serotonin metabolism in the rat brain.
    Experientia, 1971, Mar-15, Volume: 27, Issue:3

    Topics: Adrenocorticotropic Hormone; Animals; Brain; Brain Chemistry; Carbamates; Corticosterone; Hydroxyindoleacetic Acid; Male; Mixed Function Oxygenases; Naphthalenes; Phenylalanine; Rats; Reserpine; Serotonin; Stimulation, Chemical; Tryptophan

1971
Affinity label for the tRNA binding site on the Escherichia coli ribosome.
    Biochimica et biophysica acta, 1972, Jul-31, Volume: 272, Issue:4

    Topics: Bacterial Proteins; Binding Sites; Carbamates; Centrifugation, Density Gradient; Chemical Phenomena; Chemistry; Electrophoresis, Disc; Escherichia coli; Molecular Weight; Nitrobenzenes; Nitrophenols; Phenylalanine; Polynucleotides; Ribosomes; RNA, Transfer; Sodium Dodecyl Sulfate; Tritium; Uracil Nucleotides

1972
Proteins at the tRNA binding sites of Escherichia coli ribosomes.
    Proceedings of the National Academy of Sciences of the United States of America, 1974, Volume: 71, Issue:1

    Topics: Animals; Antigen-Antibody Complex; Autoradiography; Bacterial Proteins; Binding Sites; Carbamates; Centrifugation, Density Gradient; Electrophoresis, Polyacrylamide Gel; Escherichia coli; Immunoassay; Molecular Weight; Nitrophenols; Phenylalanine; Protein Binding; Puromycin; Rabbits; Ribosomes; RNA, Transfer; Tritium

1974
The relation of the -amino group of trypsin to enzyme function and zymogen activation.
    Biochemistry, 1973, Jan-30, Volume: 12, Issue:3

    Topics: Benzoates; Carbamates; Carbon Isotopes; Catalysis; Chemical Phenomena; Chemistry; Cyanates; Enzyme Activation; Guanidines; Isoflurophate; Isoleucine; Kinetics; Nitrobenzenes; Phenylalanine; Potassium; Protein Denaturation; Structure-Activity Relationship; Succinimides; Thiocarbamates; Thiocyanates; Trypsin; Trypsin Inhibitors; Trypsinogen

1973
Pantetheine-linked peptide intermediates in gramicidin S and tyrocidine biosynthesis.
    Proceedings of the National Academy of Sciences of the United States of America, 1971, Volume: 68, Issue:9

    Topics: Asparagine; Carbamates; Carbon Isotopes; Chromatography, Gel; Chromatography, Thin Layer; Enzymes; Hydroxybutyrates; Pepsin A; Peptide Biosynthesis; Peptide Chain Initiation, Translational; Peptides; Phenylalanine; Proline; Sulfhydryl Compounds; Tyrothricin

1971
Effects of -radiation on concentrated solutions of -chymotrypsin.
    Radiation research, 1972, Volume: 49, Issue:1

    Topics: Air; Albumins; Anilides; Carbamates; Caseins; Chymotrypsin; Cobalt Isotopes; Electrophoresis; Esters; Hemoglobins; Hydrochloric Acid; Imidazoles; Leucine; Nitro Compounds; Nitrogen; Nitrophenols; Peptides; Phenylalanine; Radiation Effects; Radiochemistry; Riboflavin; Solutions; Structure-Activity Relationship; Tryptophan; Tyrosine

1972
Carbamyl- and methylthiocarbamylinsulins.
    Biochimica et biophysica acta, 1972, May-18, Volume: 263, Issue:3

    Topics: Animals; Binding Sites; Biological Assay; Blood Glucose; Carbamates; Cattle; Chemical Phenomena; Chemistry; Chromatography, Ion Exchange; Chromatography, Thin Layer; Cyanates; Guinea Pigs; Insulin; Insulin Antibodies; Isoelectric Focusing; Male; Oxidation-Reduction; Phenylalanine; Rabbits; Radioimmunoassay; Sulfites; Thiocarbamates; Thiocyanates

1972
A chemical and crystallographic study of carbamyl-chymotrypsin A.
    Biochemistry, 1972, May-09, Volume: 11, Issue:10

    Topics: Acetates; Amino Acids; Animals; Binding Sites; Carbamates; Carbon Isotopes; Cattle; Chemical Phenomena; Chemistry; Chromatography, Gel; Chromatography, Ion Exchange; Chymotrypsin; Cyanates; Cyanides; Cyanogen Bromide; Cysteine; Glycine; Models, Structural; Nitrophenols; Pancreas; Phenylalanine; Protein Conformation; Serine; Succinates; Water; X-Ray Diffraction

1972
Inducible synthesis of bacterial luciferase: specificity and kinetics of induction.
    Journal of bacteriology, 1967, Volume: 94, Issue:5

    Topics: Amines; Amino Acids; Ammonium Chloride; Arginine; Azo Compounds; Bacteria; Bacterial Proteins; Carbamates; Carbon Isotopes; Chloramphenicol; Enzyme Induction; Fluorine; Fluorouracil; Guanidines; Kinetics; Light; Luciferases; Marine Biology; Nitrates; Phenylalanine; Propylamines; Puromycin; RNA, Messenger; Urea

1967
Studies on the mechanism of NK cell lysis.
    Journal of immunology (Baltimore, Md. : 1950), 1982, Volume: 128, Issue:4

    Topics: Animals; Arginine; Calcium; Carbamates; Cytotoxicity, Immunologic; Dose-Response Relationship, Immunologic; Female; Immunity, Cellular; Indoles; Male; Mice; Mice, Inbred CBA; Nitrobenzoates; Phenylalanine; Phenylcarbamates; Protease Inhibitors; Tosyllysine Chloromethyl Ketone; Tosylphenylalanyl Chloromethyl Ketone; Tubercidin; Tyrosine

1982
Off-line combination of liquid chromatography and field desorption mass spectrometry: principles and environmental, medical and pharmaceutical applications.
    Journal of chromatography, 1982, Apr-09, Volume: 251, Issue:2

    Topics: Barbiturates; Carbamates; Chromatography, High Pressure Liquid; Cyclophosphamide; Humans; Mass Spectrometry; Phenylalanine; Phenylurea Compounds; Reference Values; Thiocarbamates; Tyrosine

1982
Insulinotropic action of meglitinide analogs: concentration-response relationship and nutrient dependency.
    Diabetes research (Edinburgh, Scotland), 1994, Volume: 27, Issue:2

    Topics: Animals; Benzamides; Carbamates; Cyclohexanes; Female; Glucose; Hypoglycemic Agents; In Vitro Techniques; Indoles; Insulin; Insulin Secretion; Islets of Langerhans; Isoindoles; Molecular Structure; Nateglinide; Phenylalanine; Piperidines; Rats; Structure-Activity Relationship; Succinates

1994
Capillary zone electrophoresis study of naphthylethylcarbamoylated beta-cyclodextrins.
    Analytical chemistry, 1995, Jan-01, Volume: 67, Issue:1

    Topics: Aminobutyrates; beta-Cyclodextrins; Carbamates; Carbohydrate Sequence; Chromatography, High Pressure Liquid; Cyclodextrins; Electrophoresis; Glycine; Molecular Sequence Data; Nitrobenzoates; Phenylalanine; Stereoisomerism

1995
Conformational analysis of non-sulfonylurea hypoglycemic agents of the meglitinide family.
    Biochemical pharmacology, 1995, Nov-27, Volume: 50, Issue:11

    Topics: Benzamides; Carbamates; Cyclohexanes; Drug Design; Glyburide; Hypoglycemic Agents; Indoles; Isoindoles; Molecular Conformation; Nateglinide; Phenylalanine; Piperidines; Stereoisomerism; Structure-Activity Relationship; Sulfonylurea Compounds

1995
Insulinotropic action of meglitinide analogues: modulation by an activator of ATP-sensitive K+ channels and high extracellular K+ concentrations.
    Pharmacological research, 1995, Volume: 32, Issue:3

    Topics: Animals; Benzamides; Carbamates; Cyclohexanes; Female; Hypoglycemic Agents; Indoles; Insulin; Insulin Secretion; Islets of Langerhans; Isoindoles; Nateglinide; Phenylalanine; Piperidines; Potassium; Rats

1995
Effects of the methyl esters of pyruvate, succinate and glutamate on the secretory response to meglitinide analogues in rat pancreatic islets.
    Pharmacological research, 1996, Volume: 33, Issue:3

    Topics: Animals; Carbamates; Cells, Cultured; Cyclohexanes; Glucose; Glutamates; Hypoglycemic Agents; Indoles; Insulin; Insulin Secretion; Islets of Langerhans; Isoindoles; Nateglinide; Phenylalanine; Piperidines; Pyruvates; Rats; Succinates

1996
Stimulation of insulin and somatostatin release by two meglitinide analogs.
    Endocrine, 1997, Volume: 7, Issue:3

    Topics: Animals; Benzamides; Blood Glucose; Carbamates; Cyclohexanes; Female; Glucagon; Hypoglycemic Agents; Insulin; Insulin Secretion; Islets of Langerhans; Nateglinide; Perfusion; Phenylalanine; Piperidines; Rats; Rats, Wistar; Somatostatin

1997
Amino acid residues involved in the interaction of acetylcholinesterase and butyrylcholinesterase with the carbamates Ro 02-0683 and bambuterol, and with terbutaline.
    Biochimica et biophysica acta, 1999, Aug-17, Volume: 1433, Issue:1-2

    Topics: Acetylcholinesterase; Amino Acids; Animals; Binding Sites; Butyrylcholinesterase; Carbamates; Cholinesterase Inhibitors; Humans; Isoleucine; Kinetics; Mice; Models, Molecular; Mutagenesis, Site-Directed; Mutation; Phenylalanine; Protein Conformation; Quaternary Ammonium Compounds; Terbutaline

1999
Structure based development of novel specific inhibitors for cathepsin L and cathepsin S in vitro and in vivo.
    FEBS letters, 1999, Sep-10, Volume: 458, Issue:1

    Topics: Animals; Carbamates; Cathepsin L; Cathepsins; Cells, Cultured; Chromatography, High Pressure Liquid; Computer Graphics; Cysteine Endopeptidases; Cysteine Proteinase Inhibitors; Drug Design; Endopeptidases; Humans; Intestine, Small; Kinetics; Leucine; Liver; Lysosomes; Mice; Phenylalanine; Rats; Recombinant Proteins; Spleen; Structure-Activity Relationship; Substrate Specificity; Time Factors

1999
Tissue selectivity of antidiabetic agent nateglinide: study on cardiovascular and beta-cell K(ATP) channels.
    The Journal of pharmacology and experimental therapeutics, 1999, Volume: 291, Issue:3

    Topics: Animals; Aorta, Thoracic; Carbamates; Cardiovascular System; Coronary Vessels; Cyclohexanes; Glyburide; Heart; Hypoglycemic Agents; Islets of Langerhans; Male; Muscle, Smooth, Vascular; Nateglinide; Phenylalanine; Piperidines; Potassium Channels; Potassium Channels, Inwardly Rectifying; Rats; Rats, Sprague-Dawley; Swine

1999
Selectivity of prandial glucose regulators: nateglinide, but not repaglinide, accelerates exocytosis in rat pancreatic A-cells.
    European journal of pharmacology, 1999, Dec-10, Volume: 386, Issue:1

    Topics: Animals; ATP-Binding Cassette Transporters; Calcium; Carbamates; Cyclohexanes; Eating; Electrophysiology; Exocytosis; Glucagon; Glucose; Hypoglycemic Agents; In Vitro Techniques; Islets of Langerhans; KATP Channels; Kinetics; Male; Nateglinide; Patch-Clamp Techniques; Phenylalanine; Piperidines; Potassium Channel Blockers; Potassium Channels; Potassium Channels, Inwardly Rectifying; Rats; Rats, Inbred Lew; Stimulation, Chemical

1999
Pancreatic beta-cell K(ATP) channel activity and membrane-binding studies with nateglinide: A comparison with sulfonylureas and repaglinide.
    The Journal of pharmacology and experimental therapeutics, 2000, Volume: 293, Issue:2

    Topics: Animals; ATP-Binding Cassette Transporters; Binding, Competitive; Carbamates; Cell Membrane; Cell Separation; Cells, Cultured; Cyclohexanes; Glucose; Glyburide; Glycosyltransferases; Humans; Hypoglycemia; Hypoglycemic Agents; In Vitro Techniques; Insulin; Islets of Langerhans; KATP Channels; Kinetics; Male; Membrane Proteins; Nateglinide; Patch-Clamp Techniques; Phenylalanine; Piperidines; Potassium Channel Blockers; Potassium Channels; Potassium Channels, Inwardly Rectifying; Rats; Rats, Sprague-Dawley; Repressor Proteins; Saccharomyces cerevisiae Proteins; Sulfonylurea Compounds

2000
Differential effects of short and long duration insulinotropic agents on meal-related glucose excursions.
    Diabetes, obesity & metabolism, 2001, Volume: 3, Issue:2

    Topics: Animals; Blood Glucose; Carbamates; Cyclohexanes; Food; Glipizide; Glucagon; Insulin; Insulin Secretion; Male; Nateglinide; Phenylalanine; Piperidines; Rats; Rats, Sprague-Dawley

2001
Alpha-ketoester-based photobiological switches: synthesis, peptide chain extension and assay against alpha-chymotrypsin.
    Bioorganic & medicinal chemistry letters, 2001, Sep-17, Volume: 11, Issue:18

    Topics: Binding Sites; Biochemistry; Carbamates; Chymotrypsin; Drug Evaluation, Preclinical; Peptides; Phenylalanine; Photochemistry; Serine Proteinase Inhibitors; Structure-Activity Relationship; Ultraviolet Rays

2001
Effect of insulinotropic agent nateglinide on Kv and Ca(2+) channels in pancreatic beta-cell.
    European journal of pharmacology, 2001, Sep-14, Volume: 427, Issue:2

    Topics: Animals; Calcium Channels; Carbamates; Cyclohexanes; Dose-Response Relationship, Drug; Electric Stimulation; Glyburide; Hypoglycemic Agents; Insulin; Insulin Secretion; Islets of Langerhans; Male; Membrane Potentials; Nateglinide; Patch-Clamp Techniques; Phenylalanine; Piperidines; Potassium Channels; Rats; Rats, Sprague-Dawley

2001
Type 2 diabetes management.
    British journal of community nursing, 2002, Volume: 7, Issue:1

    Topics: Carbamates; Cyclohexanes; Diabetes Mellitus, Type 2; Drug Therapy, Combination; Humans; Hypoglycemic Agents; Metformin; Nateglinide; Phenylalanine; Piperidines

2002
Interaction of nateglinide with K(ATP) channel in beta-cells underlies its unique insulinotropic action.
    European journal of pharmacology, 2002, May-03, Volume: 442, Issue:1-2

    Topics: Adenosine Triphosphate; Animals; Carbamates; Cyclohexanes; Dose-Response Relationship, Drug; Glucose; Glyburide; Hypoglycemic Agents; Insulin; Insulin Secretion; Islets of Langerhans; Kinetics; Male; Membrane Potentials; Nateglinide; Phenylalanine; Piperidines; Potassium Channel Blockers; Potassium Channels; Rats; Rats, Sprague-Dawley; Sulfonylurea Compounds; Time Factors

2002
Nateglinide, but not repaglinide, stimulates growth hormone release in rat pituitary cells by inhibition of K channels and stimulation of cyclic AMP-dependent exocytosis.
    European journal of endocrinology, 2002, Volume: 147, Issue:1

    Topics: Animals; Calcium; Carbamates; Cyclic AMP; Cyclic AMP-Dependent Protein Kinases; Cyclohexanes; Delayed Rectifier Potassium Channels; Exocytosis; Growth Hormone; Growth Hormone-Releasing Hormone; Hypoglycemic Agents; Male; Membrane Potentials; Nateglinide; Patch-Clamp Techniques; Phenylalanine; Piperidines; Pituitary Gland; Potassium; Potassium Channel Blockers; Potassium Channels; Potassium Channels, Voltage-Gated; Rats; Rats, Sprague-Dawley

2002
Differential interactions of nateglinide and repaglinide on the human beta-cell sulphonylurea receptor 1.
    Diabetes, 2002, Volume: 51, Issue:9

    Topics: ATP-Binding Cassette Transporters; Binding, Competitive; Carbamates; Cell Line; Cyclohexanes; Drug Interactions; Electrophysiology; Humans; Islets of Langerhans; Nateglinide; Phenylalanine; Piperidines; Potassium Channels; Potassium Channels, Inwardly Rectifying; Receptors, Drug; Sulfonylurea Receptors; Tolbutamide

2002
Glucose-dependent and glucose-sensitizing insulinotropic effect of nateglinide: comparison to sulfonylureas and repaglinide.
    International journal of experimental diabetes research, 2001, Volume: 2, Issue:1

    Topics: Animals; Carbamates; Cyclohexanes; Glucose; Hypoglycemic Agents; Insulin; Insulin Secretion; Islets of Langerhans; Kinetics; Male; Nateglinide; Phenylalanine; Piperidines; Rats; Rats, Sprague-Dawley; Sulfonylurea Compounds

2001
Effectiveness of nateglinide on in vitro insulin secretion from rat pancreatic islets desensitized to sulfonylureas.
    International journal of experimental diabetes research, 2001, Volume: 2, Issue:1

    Topics: Animals; Carbamates; Cyclohexanes; Hypoglycemic Agents; Insulin; Insulin Secretion; Islets of Langerhans; Male; Nateglinide; Phenylalanine; Piperidines; Rats; Rats, Sprague-Dawley; Sulfonylurea Compounds

2001
[Glinides and glitazones in diabetes treatment. Are they really effective?].
    MMW Fortschritte der Medizin, 2002, May-02, Volume: 144, Issue:18

    Topics: Carbamates; Cyclohexanes; Diabetes Mellitus, Type 2; Drug Therapy, Combination; Humans; Hypoglycemic Agents; Insulin; Nateglinide; Phenylalanine; Pioglitazone; Piperidines; Rosiglitazone; Thiazoles; Thiazolidinediones; Treatment Outcome

2002
Pharmacologic restoration of the early insulin response in pre-diabetic monkeys controls mealtime glucose excursions without peripheral hyperinsulinaemia.
    Diabetologia, 2003, Volume: 46 Suppl 1

    Topics: Animals; Blood Glucose; Carbamates; Cyclohexanes; Fatty Acids, Nonesterified; Food; Glucagon; Hypoglycemic Agents; Insulin; Insulin Secretion; Kinetics; Macaca fascicularis; Male; Nateglinide; Phenylalanine; Piperidines

2003
[Differences between oral antidiabetics].
    Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke, 2003, Mar-20, Volume: 123, Issue:6

    Topics: Administration, Oral; Carbamates; Cyclohexanes; Diabetes Mellitus; Glipizide; Humans; Hypoglycemic Agents; Insulin; Insulin Secretion; Nateglinide; Phenylalanine; Piperidines; Sulfonylurea Compounds

2003
Repaglinide at a cellular level.
    Diabetes, nutrition & metabolism, 2002, Volume: 15, Issue:6 Suppl

    Topics: Animals; Carbamates; Cyclohexanes; Electrophysiology; Exocytosis; Hypoglycemic Agents; Islets of Langerhans; Membrane Potentials; Nateglinide; Phenylalanine; Piperidines; Postprandial Period; Potassium Channels; Rats

2002
Glimepiride and serum adiponectin level in type 2 diabetic subjects: response to Nagasaka et al.
    Diabetes care, 2003, Volume: 26, Issue:12

    Topics: Adiponectin; Blood Glucose; Carbamates; Cyclohexanes; Diabetes Mellitus, Type 2; Humans; Hypoglycemic Agents; Intercellular Signaling Peptides and Proteins; Nateglinide; Phenylalanine; Piperidines; Proteins; Sulfonylurea Compounds

2003
Comparison of repaglinide and nateglinide in combination with metformin: response to Raskin et al.
    Diabetes care, 2003, Volume: 26, Issue:12

    Topics: Carbamates; Cyclohexanes; Diabetes Mellitus, Type 2; Drug Therapy, Combination; Glycated Hemoglobin; Humans; Hypoglycemic Agents; Metformin; Nateglinide; Phenylalanine; Piperidines

2003
Comparing the long-term cost-effectiveness of repaglinide plus metformin versus nateglinide plus metformin in type 2 diabetes patients with inadequate glycaemic control: an application of the CORE Diabetes Model in type 2 diabetes.
    Current medical research and opinion, 2004, Volume: 20 Suppl 1

    Topics: Carbamates; Cohort Studies; Computer Simulation; Cost of Illness; Cost-Benefit Analysis; Cyclohexanes; Decision Support Systems, Clinical; Diabetes Complications; Diabetes Mellitus, Type 2; Drug Therapy, Combination; Female; Glycated Hemoglobin; Health Care Costs; Humans; Male; Metformin; Middle Aged; Models, Econometric; Nateglinide; Outcome Assessment, Health Care; Phenylalanine; Piperidines; Quality-Adjusted Life Years

2004
Sulfonylurea induced beta-cell apoptosis in cultured human islets.
    The Journal of clinical endocrinology and metabolism, 2005, Volume: 90, Issue:1

    Topics: Adult; Aged; Apoptosis; Calcium; Carbamates; Cells, Cultured; Cyclohexanes; Dose-Response Relationship, Drug; Glyburide; Humans; Hypoglycemic Agents; Insulin; Islets of Langerhans; Middle Aged; Nateglinide; Phenylalanine; Piperidines

2005
Treating type 2 diabetes. When diet and exercise aren't enough, a broad range of medications can help control our blood sugar.
    Health news (Waltham, Mass.), 2004, Volume: 10, Issue:8

    Topics: Carbamates; Cyclohexanes; Diabetes Mellitus, Type 2; Drug Administration Schedule; Eating; Humans; Hypoglycemic Agents; Nateglinide; Phenylalanine; Piperidines

2004
[Synthesis and insulinotropic activity of 2-benzylidenesuccinic acid derivatives].
    Yao xue xue bao = Acta pharmaceutica Sinica, 2005, Volume: 40, Issue:12

    Topics: Animals; Benzylidene Compounds; Blood Glucose; Carbamates; Cyclohexanes; Hypoglycemic Agents; Indoles; Isoindoles; Mice; Molecular Structure; Nateglinide; Phenylalanine; Piperidines; Structure-Activity Relationship; Succinates

2005
Glibenclamide attenuates the antiarrhythmic effect of endotoxin with a mechanism not involving K(ATP) channels.
    Vascular pharmacology, 2007, Volume: 46, Issue:2

    Topics: Action Potentials; Adenosine Triphosphate; Animals; Arrhythmias, Cardiac; Blood Pressure; Carbamates; Cyclohexanes; Disease Models, Animal; Drug Interactions; Endotoxemia; Glyburide; Heart Atria; Heart Conduction System; Lipopolysaccharides; Male; Myocardial Ischemia; Nateglinide; Phenylalanine; Piperidines; Potassium Channel Blockers; Potassium Channels; Rats; Rats, Sprague-Dawley; Tachycardia, Ventricular; Tetraethylammonium; Time Factors; Ventricular Fibrillation; Ventricular Premature Complexes

2007
Testing the bipartite model of the sulfonylurea receptor binding site: binding of A-, B-, and A + B-site ligands.
    The Journal of pharmacology and experimental therapeutics, 2007, Volume: 322, Issue:2

    Topics: Amino Acid Substitution; Animals; ATP-Binding Cassette Transporters; Binding Sites; Binding, Competitive; Carbamates; Cell Line; Cyclohexanes; Dose-Response Relationship, Drug; Glyburide; Hypoglycemic Agents; KATP Channels; Ligands; Mice; Molecular Structure; Nateglinide; Phenylalanine; Piperidines; Potassium Channels; Potassium Channels, Inwardly Rectifying; Protein Binding; Radioligand Assay; Rats; Receptors, Drug; Sulfonylurea Compounds; Sulfonylurea Receptors; Transfection

2007
Postprandial hyperglycemia: are all sulfonylureas created equal?
    The American journal of cardiology, 2008, Feb-15, Volume: 101, Issue:4

    Topics: Carbamates; Cyclohexanes; Glipizide; Humans; Hyperglycemia; Hyperlipidemias; Hypoglycemic Agents; Nateglinide; Phenylalanine; Piperidines; Postprandial Period; Sulfonylurea Compounds

2008
Hypoglycaemia with oral antidiabetic drugs: results from prescription-event monitoring cohorts of rosiglitazone, pioglitazone, nateglinide and repaglinide.
    Drug safety, 2009, Volume: 32, Issue:5

    Topics: Administration, Oral; Adult; Adverse Drug Reaction Reporting Systems; Carbamates; Cohort Studies; Cyclohexanes; Diabetes Mellitus, Type 2; Drug Monitoring; Drug Prescriptions; Female; Humans; Hypoglycemia; Hypoglycemic Agents; Incidence; Male; Middle Aged; Nateglinide; Phenylalanine; Pioglitazone; Piperidines; Rosiglitazone; Sex Factors; Thiazolidinediones

2009
Glinide, but not sulfonylurea, can evoke insulin exocytosis by repetitive stimulation: imaging analysis of insulin exocytosis by secretagogue-induced repetitive stimulations.
    Experimental diabetes research, 2009, Volume: 2009

    Topics: Animals; Calcium; Carbamates; Cell Fusion; Cells, Cultured; Cyclohexanes; Exocytosis; Glucose; Hypoglycemic Agents; Insulin; Insulin Secretion; Insulin-Secreting Cells; Mice; Mice, Inbred C57BL; Microscopy, Fluorescence; Nateglinide; Phenylalanine; Piperidines; Sulfonylurea Compounds

2009
Diabetes under control: Understanding oral antidiabetic agents.
    The American journal of nursing, 2010, Volume: 110, Issue:2

    Topics: Administration, Oral; Biguanides; Carbamates; Cyclohexanes; Diabetes Mellitus, Type 2; Dipeptidyl-Peptidase IV Inhibitors; Drug Combinations; Drug Therapy, Combination; Glycoside Hydrolase Inhibitors; Humans; Hypoglycemic Agents; Nateglinide; Phenylalanine; Piperidines; Sulfonylurea Compounds

2010
Hypersensitivity to repaglinide.
    Journal of investigational allergology & clinical immunology, 2011, Volume: 21, Issue:3

    Topics: Carbamates; Cyclohexanes; Diabetes Mellitus, Type 2; Drug Hypersensitivity; Erythema; Exanthema; Humans; Hypoglycemic Agents; Male; Middle Aged; Nateglinide; Patch Tests; Phenylalanine; Piperidines

2011
From evidence assessments to coverage decisions?: the case example of glinides in Germany.
    Health policy (Amsterdam, Netherlands), 2012, Volume: 104, Issue:1

    Topics: Carbamates; Cost Control; Cost-Benefit Analysis; Costs and Cost Analysis; Cyclohexanes; Diabetes Mellitus; Eligibility Determination; Evidence-Based Medicine; Germany; Health Care Reform; Health Policy; Humans; Hypoglycemic Agents; Insurance Coverage; Nateglinide; National Health Programs; Phenylalanine; Piperidines; Prescription Drugs; Reimbursement Mechanisms; Technology Assessment, Biomedical

2012
Effects of nateglinide and repaglinide administered intracerebroventricularly on the CA3 hippocampal neuronal cell death and hyperglycemia induced by kainic acid in mice.
    Brain research bulletin, 2014, Volume: 104

    Topics: Animals; Blood Glucose; CA3 Region, Hippocampal; Carbamates; Cell Death; Corticosterone; Cyclohexanes; Excitatory Amino Acid Agonists; Hypoglycemic Agents; Infusions, Intraventricular; Insulin; Kainic Acid; Male; Mice; Mice, Inbred ICR; Nateglinide; Neurons; Phenylalanine; Piperidines

2014
Biomedical Informatics Approaches to Identifying Drug-Drug Interactions: Application to Insulin Secretagogues.
    Epidemiology (Cambridge, Mass.), 2017, Volume: 28, Issue:3

    Topics: Area Under Curve; Carbamates; Cyclohexanes; Databases, Factual; Diabetes Mellitus, Type 2; Drug Interactions; Glipizide; Glyburide; Humans; Hypoglycemia; Hypoglycemic Agents; Medical Informatics; Nateglinide; Pharmacoepidemiology; Phenylalanine; Piperidines; Sulfonylurea Compounds

2017
Development of Novel Peptide-Based Michael Acceptors Targeting Rhodesain and Falcipain-2 for the Treatment of Neglected Tropical Diseases (NTDs).
    Journal of medicinal chemistry, 2017, 08-24, Volume: 60, Issue:16

    Topics: Antimalarials; Carbamates; Cathepsin L; Cysteine Endopeptidases; Cysteine Proteinase Inhibitors; Dipeptides; HeLa Cells; Humans; Hydrogen Bonding; Malaria; Molecular Docking Simulation; Molecular Dynamics Simulation; Neglected Diseases; Phenylalanine; Plasmodium falciparum; Stereoisomerism; Structure-Activity Relationship; Trypanocidal Agents; Trypanosoma brucei brucei; Trypanosomiasis, African

2017
Characterization of the Neurochemical and Behavioral Effects of Solriamfetol (JZP-110), a Selective Dopamine and Norepinephrine Reuptake Inhibitor.
    The Journal of pharmacology and experimental therapeutics, 2018, Volume: 366, Issue:2

    Topics: Animals; Behavior, Animal; Biological Transport; Carbamates; Cell Line; Dopamine; Locomotion; Male; Neurochemistry; Norepinephrine; Phenylalanine; Rats; Rats, Sprague-Dawley

2018
Drug updates and approvals: 2019 in review.
    The Nurse practitioner, 2019, Volume: 44, Issue:12

    Topics: Antibodies, Monoclonal; Azetidines; Benzyl Compounds; beta-Cyclodextrins; Carbamates; Clobetasol; Drug Approval; Drug Combinations; Formoterol Fumarate; Heterocyclic Compounds, 3-Ring; Humans; Lamivudine; Nicotinic Acids; Oxazines; Phenylalanine; Piperazines; Pregnanolone; Pyridones; Tropanes; United States; United States Food and Drug Administration

2019
New Drugs 2020, part 1.
    Nursing, 2020, Volume: 50, Issue:2

    Topics: Antibodies, Monoclonal; Benzofurans; Carbamates; Drug Approval; Humans; Phenylalanine; Piperidines; Purines; Tetracyclines; United States; United States Food and Drug Administration

2020
Clinically relevant effects of solriamfetol on excessive daytime sleepiness: a posthoc analysis of the magnitude of change in clinical trials in adults with narcolepsy or obstructive sleep apnea.
    Journal of clinical sleep medicine : JCSM : official publication of the American Academy of Sleep Medicine, 2021, 04-01, Volume: 17, Issue:4

    Topics: Adult; Carbamates; Disorders of Excessive Somnolence; Humans; Narcolepsy; Phenylalanine; Sleep Apnea, Obstructive

2021
Solriamfetol for attention deficit hyperactivity disorder.
    CNS spectrums, 2022, Volume: 27, Issue:6

    Topics: Attention Deficit Disorder with Hyperactivity; Carbamates; Humans; Phenylalanine

2022
Enantioseparation of solriamfetol and its major impurity phenylalaninol by capillary electrophoresis using sulfated gamma cyclodextrin.
    Electrophoresis, 2021, Volume: 42, Issue:17-18

    Topics: Carbamates; Electrophoresis, Capillary; gamma-Cyclodextrins; Phenylalanine; Stereoisomerism; Sulfates

2021
Pitolisant, a wake-promoting agent devoid of psychostimulant properties: Preclinical comparison with amphetamine, modafinil, and solriamfetol.
    Pharmacology research & perspectives, 2021, Volume: 9, Issue:5

    Topics: 3,4-Dihydroxyphenylacetic Acid; Adrenergic Uptake Inhibitors; Amphetamine; Animals; Carbamates; Corpus Striatum; Disorders of Excessive Somnolence; Dopamine; Dopamine Plasma Membrane Transport Proteins; Dopamine Uptake Inhibitors; Drug Evaluation, Preclinical; Drug Inverse Agonism; Feeding Behavior; Histamine Antagonists; Locomotion; Mice; Modafinil; Narcolepsy; Neostriatum; Norepinephrine Plasma Membrane Transport Proteins; Nucleus Accumbens; Phenylalanine; Piperidines; Receptors, Histamine H3; Sleep Apnea, Obstructive; Wakefulness-Promoting Agents

2021
Long-term effects of solriamfetol on quality of life and work productivity in participants with excessive daytime sleepiness associated with narcolepsy or obstructive sleep apnea.
    Journal of clinical sleep medicine : JCSM : official publication of the American Academy of Sleep Medicine, 2021, 10-01, Volume: 17, Issue:10

    Topics: Adult; Carbamates; Disorders of Excessive Somnolence; Humans; Narcolepsy; Phenylalanine; Quality of Life; Sleep Apnea, Obstructive

2021
Macrocyclic glycopeptides- and derivatized cyclofructan-based chiral stationary phases for the enantioseparation of fluorinated ß-phenylalanine analogs.
    Journal of pharmaceutical and biomedical analysis, 2022, Sep-20, Volume: 219

    Topics: Carbamates; Chromatography, High Pressure Liquid; Glycopeptides; Phenylalanine; Stereoisomerism; Vancomycin

2022
Solriamfetol Titration and AdministRaTion (START) in Patients with Obstructive Sleep Apnea: A Retrospective Chart Review and Hypothetical Patient Scenario.
    Advances in therapy, 2022, Volume: 39, Issue:9

    Topics: Adult; Carbamates; Disorders of Excessive Somnolence; Female; Humans; Male; Middle Aged; Phenylalanine; Retrospective Studies; Sleep Apnea, Obstructive

2022
Development of Sesamol Carbamate-L-Phenylalanine Prodrug Targeting L-Type Amino Acid Transporter1 (LAT1) as a Potential Antiproliferative Agent against Melanoma.
    International journal of molecular sciences, 2022, Jul-30, Volume: 23, Issue:15

    Topics: Amino Acids; Benzodioxoles; Biological Transport; Carbamates; HEK293 Cells; Humans; Large Neutral Amino Acid-Transporter 1; Leucine; Melanoma; Phenols; Phenylalanine; Prodrugs; Syndrome

2022